Tommi leads Blueprint Genetics as VP & GM of Specialty Genetics and is also a co-founder of the company. He has been running Blueprint Genetics since the beginning, growing the company into a leading clinical genetic testing provider. Over time he has held various responsibilities focused around sales and marketing, organizational development, business development and financing. Prior to Blueprint Genetics he founded a data analytics company called Whitevector and grew it to the Nordics and UK. Tommi holds a MSc (Tech) from the Helsinki University of Technology where he studied business strategy and applied mathematics.
Juha is the Executive Director of Medical & Lab Director at Blueprint Genetics. He is a co-founder of the company as well. Juha is responsible for supervising laboratory production and for designing new diagnostic tests. On a daily basis, he participates in the clinical evaluation of genetic findings and further develops the company's variant classification and interpretation practices in collaboration with a team of geneticists. Juha has an MD-PhD from the University of Turku. In 2006, Juha completed his fellowship program in clinical physiology and nuclear medicine. The following year, he became a docent. From 2007 to 2009, he joined the University of California San Francisco’s Cardiac Stem Cell Translational Development Program as a postdoctoral researcher and later as a research specialist. He also teaches at the University of Helsinki.
Samuel is the Executive Director of Strategy at Blueprint Genetics as well as a co-founder of the company. He is an expert in genome analysis technologies and has extensive experience in bioinformatics and cancer genomics research. Samuel received his PhD from the University of Helsinki and completed his postdoctoral research at Stanford University. At Stanford, he developed high-throughput sequencing technologies such as Oligonucleotide-Selective Sequencing (OS-Seq™). He is an adjunct professor in genetics at the University of Helsinki, an author of several high-impact publications, and an inventor and patent holder of DNA sequencing methods.
Tero-Pekka is the Executive Director of Medical, and also a co-founder at Blueprint Genetics. He is based in San Francisco and holds various responsibilities in the North American operations of the company. Tero-Pekka has an MD-PhD degree and is specialized in pediatrics and pediatric cardiology. He has a PhD in molecular and cellular biology as well. During his 3-year postdoctoral training at Stanford University School of Medicine, he focused on the molecular genetic mechanisms of cardiovascular disease.
Sofia is the Senior Director of Customer Experience and Brand at Blueprint Genetics. She oversees overall experience of our products and services, brand marketing as well as Group Client Services. Sofia has an extensive track record in marketing and brand building from consumer goods to life science. She holds a MSc in economics and business administration from Hanken School of Economics where she studied marketing and law.
Jussi is the Executive Director of ADx Technology at Blueprint Genetics. He is in charge of directing and developing the company's data science, artificial intelligence, and software technology efforts. He has a Master’s Degree in computer science and a PhD in molecular medicine. He has worked as a visiting scholar and research affiliate at the Broad Institute of MIT and Harvard, and as an Assistant Professor and manager of the Bioinformatics Center at the University of Eastern Finland. Jussi has an extensive track record of publishing scientific publications, software, and databases in the fields of genetics, bioinformatics, and data science, as well as experience from co-founding two life-science start-ups.
As Senior Director of Operations, Mikko is responsible for operations including safety, quality, delivery and cost of order-to-delivery process globally. He oversees supply chain management and continuous improvement initiatives across the company. He has 20 years of experience in regulated businesses like the medical device industry and food industries, and he has extensive experience in various development and leadership positions in health-tech corporations like GE Healthcare and Danaher. He is an expert in developing processes by using continuous improvement methods. Before Blueprint, he was development manager at HUS, the hospital district of Helsinki and Uusimaa in Finland. Mikko has an MSc in Industrial Engineering and Management from the Lappeenranta University of Technology.
Meena leads the sales and marketing operations in North America and other regions including Australia and New Zealand. During her years at Blueprint Genetics, she started as the Canadian director of sales and has been a vital part of driving growth in the NA region overall. Meena has a strong desire to build awareness and develop the genetic testing market with a patient-first mindset. Her experience in both industry and clinic have allowed her to develop strengths in sales, business development and strategy, patient counseling, and understanding the genetic diagnostics space. Genetics and genomics have always been a passion, from working on the Wiscott-Aldrich syndrome pathway in fruit flies and Bardet-Biedl syndrome in microscopic worms, obtaining a Master of Science in Human Genetics from Sarah Lawrence College and working as a board certified genetic counselor, to now helping bring Blueprint Genetics diagnostic innovations to patients and clinicians around the world.
As Senior Director of Finance, Kirsi is responsible of Blueprint Genetics financials, including statutory and management reporting, accounting process, taxation, and budgeting and forecasting. She oversees the financials across the different global legal entities. Kirsi is a finance professional with over 10 years of experience in various finance roles in global stock listed companies. Kirsi has an MSc in Economics and Business Administration from Helsinki School of Economics and CEMS Master in International Management from Vienna University of Economics and Business.